胰岛素降解酶 (Insulin-degrading enzyme) 是一种具有胰岛素降解活性的 Zn2+ 依赖性内肽酶,属于肽酶 M16 家族。IDE 通过降低胰岛素水平来调控血糖稳态,同时,IDE 也能参与肽类激素信号传导级联反应,降解多种其他重要的肽类,包括淀粉样前体蛋白 (APP) 衍生的肽段、胰岛淀粉样多肽 (IAPP)、胰高血糖素 (Glucagon)、利钠肽 (ANP、BNP、CNP)、缓激肽 (Bradykinin)、激肽 (Kallidin) 等。此外,IDE 在清除脑内积聚的 Aβ 斑块方面起到至关重要的作用,从而可能缓解与 Aβ 相关的认知损伤和神经退行性疾病。IDE 还参与抗原加工,通过降解 MAGEA3 衍生肽段,使其成为适合呈递给细胞毒性T淋巴细胞的抗原肽段,参与免疫应答。
IDE 是调节多种激素和肽类信号传递的重要酶,在代谢性疾病、神经退行性疾病、心血管疾病及免疫相关疾病研究中发挥重要作用[1]。
IDE (Insulin-degrading enzyme) is a Zn2+-dependent endopeptidase with insulin-degrading activity, belonging to the peptidase M16 family. IDE regulates blood glucose homeostasis by lowering insulin levels, while also participating in peptide hormone signaling cascades by degrading a variety of other important peptides, including APP-derived peptides, IAPP, Glucagon, natriuretic peptides (ANP, BNP, CNP), Bradykinin, Kallidin, and others. Additionally, IDE plays a crucial role in clearing Aβ plaques accumulated in the brain, which may alleviate cognitive impairments and neurodegenerative diseases associated with Aβ. IDE is also involved in antigen processing, degrading MAGEA3-derived peptides to produce antigenic peptides that are presented to cytotoxic T lymphocytes, contributing to the immune response.
IDE is an important enzyme in regulating various hormone and peptide signaling pathways and plays a critical role in research related to metabolic diseases, neurodegenerative diseases, cardiovascular diseases, and immune-related diseases[1].
6bK formate 是一种有效且具有选择性的胰岛素降解酶 (IDE) 抑制剂(IC50 为 50 nM),可增加高脂饲料喂养小鼠的胰岛素循环,急性给药能增强口服葡萄糖耐受性(在高脂饲料喂养小鼠中尤为显著),可用于 2 型糖尿病相关研究。
6bK TFA 是一种选择性胰岛素降解酶 (IDE) 抑制剂,IC50 为 50 nM,它通过结合 IDE 的远端口袋阻断底物结合、肽段解折叠与切割过程,从而减少胰岛素、胰高血糖素和胰淀素的降解,可改善口服葡萄糖耐量但会损害腹腔注射葡萄糖耐量,可用于 2 型糖尿病的相关研究。
IDE-IN-2(Compound 4)是胰岛素降解酶(IDE)的抑制剂,根据计算机预测,其预计具有对CYP3A4、CYP2C19、hERG、NADP+、HIF1α和组氨酸激酶的抑制活性,并在抗糖尿病、抗肿瘤和抗菌方面具有潜在生物活性。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号